Presage partnered with Celgene to use Presage's technology to identify new drug combinations for solid tumors

Presage Biosciences

U.S. / Tools, Services, and Manufacturing

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Celgene Corp.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

$46,626.4m on 03/08/2013 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced